Skip to main content
Genes & Diseases logoLink to Genes & Diseases
. 2023 Nov 15;11(3):101168. doi: 10.1016/j.gendis.2023.101168

Corrigendum to “A novel FGFR1 inhibitor CYY292 suppresses tumor progression, invasion, and metastasis of glioblastoma by inhibiting the Akt/GSK3β/snail signaling axis” [Genes & Diseases 11 (2024) 479–494]

Yanran Bi a,b,1, Ruiling Zheng a,1, Jiahao Hu c,1, Ruiqing Shi a, Junfeng Shi a, Yutao Wang a, Peng Wang a, Wenyi Jiang a, Gyudong Kim b,∗∗∗, Zhiguo Liu a,∗∗∗∗, Xiaokun Li a,∗∗, Li Lin a,d,
PMCID: PMC10825310  PMID: 38292171

The authors regret that in Figure 3C, the Western Blot (WB) image representing GAPDH levels was mistakenly chosen as the same image for ERK (indicated by the red dotted-line rectangle). We have attached the original WB strip for GAPDH to demonstrate that this was an unintentional error in image selection. Additionally, we noticed that the Transwell images in the two upper panels of the right column in Figure 4J are misleading due to errors in image selection. We have attached the original data to show that this was also an unintentional error. We assure you that these two corrections do not alter the scientific conclusion of the article.

Figure 3C in journal publication

Image 1

Original WB strips for Figure 3C

Image 2

Figure 4J in journal publication

Image 3

Original data

Image 4

Requested correction for Figure 3C

Image 5

Requested correction for Figure 4J

Image 6

The authors would like to apologise for any inconvenience caused.

Footnotes

Peer review under responsibility of Chongqing Medical University.

Contributor Information

Gyudong Kim, Email: Gdkim0217@chonnam.ac.kr.

Zhiguo Liu, Email: Liucnu@163.com.

Xiaokun Li, Email: xiaokunli@wmu.edu.cn.

Li Lin, Email: linliwz@163.com.


Articles from Genes & Diseases are provided here courtesy of Chongqing Medical University

RESOURCES